Canada: Proposed Prosecution Bar In Addition To Protective Order Denied Due To Insufficient Evidence (Intellectual Property Weekly Abstracts Bulletin — Week of July 17, 2017)

PATENT DECISION

Proposed prosecution bar in addition to protective order denied due to insufficient evidence

Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC 675

Drug: Adalimumab

In this case, AbbVie brought an application against Samsung pursuant to the NOC Regulations. The parties agreed that a protective order was needed; however, Samsung wanted additional protections for its confidential information. It sought provisions that would prevent outside counsel and in-house counsel for both parties from engaging in patent prosecution activities relating to the patents in suit or adalimumab for one year after the proceeding or any other relevant litigation.

The Court held that Samsung had not adduced sufficient evidence to show that the Proposed Prosecution Bar (PPB) was necessary or reasonable. In making this determination, the Court also held that the test for a 'counsel's eyes only' (CEO) protective order was not the appropriate test to use. Moreover, Samsung was held not to have met this test.

The Court held that the PPB was more similar to a restrictive covenant or a restraint of trade than to a CEO protective order. In the employer/employee context there is a presumption that restrictive covenants are prima facie unenforceable. However, a reasonable one will be upheld. The onus of showing the reasonableness of the restrictive covenant is on the party seeking to enforce it. The Court held that the protective order provides a serious obligation not to use or disclose confidential information other than for the purposes of this proceeding. Thus, it is not reasonable to find that the PPB should be granted without concrete evidence to prove, on a balance of probabilities, that counsel are at risk to misuse the confidential information disclosed to them.

COPYRIGHT DECISION

Interim tariff found to be enforceable; copying made under the university's guidelines did not constitute fair dealing

Canadian Copyright Licensing Agency v. York University, 2017 FC 669

In the main action, the Canadian Copyright Licensing Agency ("Access") sought to enforce an Interim Tariff issued by the Copyright Board with respect to copying activities engaged by York University ("York") employees for a set period. By counterclaim, York sought a declaration that any reproductions made fell within York's Fair Dealing Guidelines and therefore constituted the exception for "fair dealing" under section 29 of the Copyright Act.

After a thorough review of the facts and witnesses, the Court addressed the issues on the main action concerning whether the Interim Tariff was enforceable against York. York argued that the Interim Tariff was not an approved tariff because: 1) it did not result from a tariff certification process, and 2) it was not published in the Canada Gazette. York submitted that since the Interim Tariff is not approved, it could not be enforced and is only binding on a user that consents to it.

The Court disagreed and found that the Interim Tariff was mandatory and enforceable against York. In the views of both Access and the Court, "the legislative history, and particularly the development of the modern enforcement provisions, confirm the legislative intent to provide collectives with effective enforcement mechanisms against users who are not subject to an agreement and who reproduce, without authority from owners or without the benefit of an exception (e.g., fair dealing), copyright protected works covered by the collectives."

The Court found that York's defence that the Interim Tariff was not enforceable since it is not an approved tariff, was essentially a collateral attack of the Copyright Board's decision. The Court noted that York was in a position to apply to judicially review the Board's decision, but chose not to do so. The Court also dismissed York's final point in the main action that there was no breach of the Interim Tariff and, if there was, York is not responsible for the breaches of the Interim Tariff. The evidence showed that there was unauthorized copying that triggered obligations under the Interim Tariff, and that these obligations belong to York.

In the counterclaim, the Court had to determine whether any copying that fall within York's Fair Dealing Guidelines constituted fair dealing pursuant to s.29 of the Act. York's Guidelines were modelled on those developed by the Association of Universities and Community Colleges, which represented the interests of York. Applying the two-part test laid down by Supreme Court of Canada jurisprudence, the Court found that the dealing was for the allowable purpose of education.

The Court then turned to the fairness analysis in the second step of the test. The Court first distinguished the Supreme Court case in CCH Canadian Ltd v Law Society of Upper Canada, 2004 SCC 13, for various reasons including that: the copying done at the Great Library in CCH was for others, not for the Library itself; the copying at issue in CCH was not the mass copying of portions of books, texts, articles, entire artistic works or portions of collections, nor was it the multiple copying of those materials into coursepacks or digital formats, as was the circumstances for this case. Moreover, a number of positive features of the policy in CCH were absent in the York situation, which pointed to the unfairness of the Guidelines at issue.

The Court then weighed the fairness factors and concluded that the Guidelines were not fair in either their terms or their application when considering the whole of the issue of fair dealing within the context of the facts of this case.

INDUSTRY UPDATE

Health Canada released the Therapeutic Products Directorate Statistical Report 2016/2017 for the Patented Medicines (Notice of Compliance) Regulations and Data Protection. The report includes information regarding trends in the eligibility of patents for listing on the Patent Register, the eligibility of drugs for listing on the Register of Innovative Drugs, and related court activity.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions